文献速递神经介入DSA

低剖面瘤内血流干扰装置WEB 17与其前代系统治疗小型颅内动脉瘤:手术安全性与可行性的对比分析

Low-Profile Intra-Aneurysmal Flow Disruptor WEB 17 versus WEB Predecessor Systems for Treatment of Small Intracranial Aneurysms: Comparative Analysis of Procedural Safety and Feasibility.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-09-05

多中心回顾性分析2011至2019年38个WEB 17治疗的3-7mm动脉瘤与70个前代版本治疗的动脉瘤,采用逆概率治疗加权比较。WEB 17组血栓栓塞事件率5.3%低于前代版本组14.3%(校正P=0.002),前代版本失败率10.3%高于WEB 17的0%(P=0.05),即刻完全闭塞率无显著差异。

要点

  • WEB 17治疗小型 bifurcation 动脉瘤的即刻完全闭塞率为57.9%,前代版本为54.3%,无显著差异。
  • WEB 17组血栓栓塞事件率5.3%,前代版本组14.3%,校正P=0.002。
  • 前代版本失败率10.3%高于WEB 17的0%(P=0.05),额外支架置入更常见(10.0% vs 2.6%,校正P=0.005)。

核心结论

  • 本研究中,WEB 17与前代版本相比可能降低血栓栓塞事件率,且不损害即刻动脉瘤闭塞率。

研究设计与样本

  • 多中心回顾性综述,纳入2011至2019年接受WEB治疗的3-7mm动脉瘤,WEB 17组38个,前代版本对照组70个,采用逆概率治疗加权比较。

诊断标准与关键数值

  • WEB 17组即刻完全闭塞率57.9%,前代版本组54.3%(校正P=0.21);WEB 17组失败率0%,前代版本组10.3%(P=0.05)。

局限性

  • 原文结论指出需要长期临床和血管造影结果分析才能得出明确结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The Woven EndoBridge 17 has recently been introduced to the market for facilitated endovascular treatment of small bifurcation aneurysms (≤7 mm) with low-profile microcatheters. We compared the Woven EndoBridge 17 with its predecessor versions in terms of procedural safety and feasibility.

MATERIALS AND METHODS: This was a multicenter review of aneurysms ranging from 3 to 7 mm treated with the Woven EndoBridge between 2011 and 2019. Aneurysm characteristics, procedural parameters, and complications were retrospectively compared between treatment with the Woven EndoBridge 17 and a control group that was treated with its predecessor versions, using inverse probability of treatment weighting.

RESULTS: Thirty-eight aneurysms treated with a Woven EndoBridge 17 (mean size, 4.9 ± 1.5 mm) and 70 treated with a predecessor version of the Woven EndoBridge 17 (mean size, 5.6 ± 1.4 mm) were included. The predecessor version of the Woven EndoBridge 17 had a higher failure rate (10.3%) than the Woven EndoBridge 17 (0%, P = .05). Additional stent placement was performed more often with the predecessor version of the Woven EndoBridge 17 (10.0%) than with the Woven EndoBridge 17 (2.6%, adjusted P = .005). The predecessor version of the Woven EndoBridge 17 was associated with a higher thromboembolic event rate (14.3%) than the Woven EndoBridge 17 (5.3%, adjusted P = .002). Neurologic complications (Woven EndoBridge 17: 2.6%; predecessor version of the Woven EndoBridge 17: 2.9%, adjusted P = 1.0) and immediate complete aneurysm occlusion rates (Woven EndoBridge 17: 57.9%; predecessor version of the Woven EndoBridge 17: 54.3%, adjusted P = .21) did not differ significantly between groups.

CONCLUSIONS: In the current study, the Woven EndoBridge 17 was associated with a potentially lower thromboembolic event rate than the predecessor version of the Woven EndoBridge 17, without compromising the immediate aneurysm occlusion rate. Long-term clinical and angiographic outcome analysis will be necessary to draw a definite conclusion.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Goertz L, Liebig T, Siebert E, et al. Low-Profile Intra-Aneurysmal Flow Disruptor WEB 17 versus WEB Predecessor Systems for Treatment of Small Intracranial Aneurysms: Comparative Analysis of Procedural Safety and Feasibility. AJNR Am J Neuroradiol. 2019. PMID: 31488499. doi:10.3174/ajnr.A6183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。